Answers are grounded in this paper and cite their sources.
Background: Pleural effusion involves the accumulation of fluid between the parietal and visceral pleura. When complicated by severe intrapleural inflammation, fibrous septations can form, leading to loculated effusions that are challenging to manage. Intrapleural fibrinolytic therapy, such as streptokinase (STK) instillation, has shown potential in enhancing drainage and resolving adhesions. Methods: This cross-sectional study included 35 patients with septated pleural effusions of various etiologies. All underwent ultrasound-guided intercostal chest tube insertion, followed by intrapleural administration of STK. Data were collected on daily fluid drainage, imaging findings (chest X-ray and ultrasound), and overall treatment response until discharge. Results: The mean patient age was 52.94 ± 8.9 years; 65.71% were male. The most common causes of effusion were tuberculosis (40%) and parapneumonic infection (28.57%). STK therapy significantly increased mean fluid drainage from 260.77 to 1306.86 mL ( P < 0.0001). Radiologic improvement was noted in most patients, with 22 (62.86%) cases achieving successful outcomes. Adhesion dissolution was observed in the majority, with complete resolution in 3 (8.57%) cases. There was no statistically significant association between the underlying etiology and treatment response. Conclusion: Intrapleural STK is a safe and effective treatment for loculated pleural effusions. It markedly enhances fluid drainage and may reduce the need for surgical intervention, regardless of the underlying cause.
No takes yet. Share an insight, caveat, or question.
Purohit et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: